Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions

[1]  M. Munafo,et al.  Causal effects of lifetime smoking on risk for depression and schizophrenia: Evidence from a Mendelian randomisation study , 2018 .

[2]  Nick C Fox,et al.  Analysis of shared heritability in common disorders of the brain , 2018, Science.

[3]  Valeriia Haberland,et al.  The MR-Base platform supports systematic causal inference across the human phenome , 2018, eLife.

[4]  Warren W. Kretzschmar,et al.  Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression , 2017, Nature Genetics.

[5]  M. Talarowska,et al.  The importance of TCF4 gene in the etiology of recurrent depressive disorders , 2018, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[6]  M. Hill,et al.  The Psychiatric Risk Gene Transcription Factor 4 (TCF4) Regulates Neurodevelopmental Pathways Associated With Schizophrenia, Autism, and Intellectual Disability , 2017, Schizophrenia bulletin.

[7]  Ian J. Deary,et al.  Association analysis in over 329,000 individuals identifies 116 independent variants influencing neuroticism , 2017, Nature Genetics.

[8]  P. Donnelly,et al.  Genome-wide genetic data on ~500,000 UK Biobank participants , 2017, bioRxiv.

[9]  Martijn P. van den Heuvel,et al.  Variation on the dopamine D2 receptor gene (DRD2) is associated with basal ganglia-to-frontal structural connectivity , 2017, NeuroImage.

[10]  M. Beckmann,et al.  Attention, cognitive control and motivation in ADHD: Linking event-related brain potentials and DNA methylation patterns in boys at early school age , 2017, Scientific Reports.

[11]  Gerome Breen,et al.  Genetic identification of brain cell types underlying schizophrenia , 2017, Nature Genetics.

[12]  M. Fichera,et al.  Familial 18q12.2 deletion supports the role of RNA‐binding protein CELF4 in autism spectrum disorders , 2017, American journal of medical genetics. Part A.

[13]  Archie Campbell,et al.  Exploration of haplotype research consortium imputation for genome-wide association studies in 20,032 Generation Scotland participants , 2017, Genome Medicine.

[14]  E. Brattico,et al.  Interaction between DRD2 variation and sound environment on mood and emotion-related brain activity , 2017, Neuroscience.

[15]  Evan Z. Macosko,et al.  Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types , 2017, Nature Genetics.

[16]  D. Weinberger,et al.  DRD2 co-expression network and a related polygenic index predict imaging, behavioral and clinical phenotypes linked to schizophrenia , 2017, Translational Psychiatry.

[17]  S. Lewis,et al.  Association of timing of menarche with depressive symptoms and depression in adolescence: Mendelian randomisation study , 2017, British Journal of Psychiatry.

[18]  Erica Y. Shen,et al.  MEF2C TRANSCRIPTION FACTOR IS ASSOCIATED WITH THE GENETIC AND EPIGENETIC RISK ARCHITECTURE OF SCHIZOPHRENIA AND IMPROVES COGNITION IN MICE , 2016, Molecular Psychiatry.

[19]  The Gene Ontology Consortium,et al.  Expansion of the Gene Ontology knowledgebase and resources , 2016, Nucleic Acids Res..

[20]  I. Deary,et al.  Cognitive ability and physical health: a Mendelian randomization study , 2016, bioRxiv.

[21]  S. Thompson,et al.  Bias due to participant overlap in two‐sample Mendelian randomization , 2016, Genetic epidemiology.

[22]  D. Ecker,et al.  Tcf4 Regulates Synaptic Plasticity, DNA Methylation, and Memory Function. , 2016, Cell reports.

[23]  Erica Y. Shen,et al.  Neuronal Deletion of Kmt2a/Mll1 Histone Methyltransferase in Ventral Striatum is Associated with Defective Spike-Timing-Dependent Striatal Synaptic Plasticity, Altered Response to Dopaminergic Drugs, and Increased Anxiety , 2016, Neuropsychopharmacology.

[24]  G. Wegener,et al.  Elevation of Il6 is associated with disturbed let-7 biogenesis in a genetic model of depression , 2016, Translational psychiatry.

[25]  Chen Zhang,et al.  Further evidence of VRK2 rs2312147 associated with schizophrenia , 2016, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[26]  D. Hinds,et al.  Identification of 15 genetic loci associated with risk of major depression in individuals of European descent , 2016, Nature Genetics.

[27]  G. Konopka,et al.  ELAVL2-regulated transcriptional and splicing networks in human neurons link neurodevelopment and autism. , 2016, Human molecular genetics.

[28]  Tom R. Gaunt,et al.  LD Hub: a centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis , 2016, bioRxiv.

[29]  Jonathan P. Beauchamp,et al.  Genetic variants associated with subjective well-being, depressive symptoms and neuroticism identified through genome-wide analyses , 2016, Nature Genetics.

[30]  BaDoi N. Phan,et al.  Psychiatric Risk Gene Transcription Factor 4 Regulates Intrinsic Excitability of Prefrontal Neurons via Repression of SCN10a and KCNQ1 , 2016, Neuron.

[31]  A. Dehghan,et al.  Polygenic dissection of major depression clinical heterogeneity , 2016, Molecular Psychiatry.

[32]  C. Spencer,et al.  A contribution of novel CNVs to schizophrenia from a genome-wide study of 41,321 subjects: CNV Analysis Group and the Schizophrenia Working Group of the Psychiatric Genomics Consortium , 2016, bioRxiv.

[33]  Klaus P. Ebmeier,et al.  Epidemiology and Heritability of Major Depressive Disorder, Stratified by Age of Onset, Sex, and Illness Course in Generation Scotland: Scottish Family Health Study (GS:SFHS) , 2015, PloS one.

[34]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[35]  Yakir A Reshef,et al.  Partitioning heritability by functional annotation using genome-wide association summary statistics , 2015, Nature Genetics.

[36]  K. Fuxe,et al.  Basimglurant for treatment of major depressive disorder: a novel negative allosteric modulator of metabotropic glutamate receptor 5 , 2015, Expert opinion on investigational drugs.

[37]  Warren W. Kretzschmar,et al.  Sparse whole genome sequencing identifies two loci for major depressive disorder , 2015, Nature.

[38]  E. Vitola,et al.  NCAM1‐TTC12‐ANKK1‐DRD2 gene cluster and the clinical and genetic heterogeneity of adults with ADHD , 2015, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[39]  M. Daly,et al.  An Atlas of Genetic Correlations across Human Diseases and Traits , 2015, Nature Genetics.

[40]  Joris M. Mooij,et al.  MAGMA: Generalized Gene-Set Analysis of GWAS Data , 2015, PLoS Comput. Biol..

[41]  C. Kieling,et al.  Cadherin‐13 gene is associated with hyperactive/impulsive symptoms in attention/deficit hyperactivity disorder , 2015, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[42]  B. Nordestgaard,et al.  Tobacco smoking is causally associated with antipsychotic medication use and schizophrenia, but not with antidepressant medication use or depression. , 2015, International journal of epidemiology.

[43]  G. Davey Smith,et al.  Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression , 2015, International journal of epidemiology.

[44]  R. Altman,et al.  The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response , 2015, Translational Psychiatry.

[45]  Meng Zhang,et al.  Amygdala NRG1–ErbB4 Is Critical for the Modulation of Anxiety-Like Behaviors , 2015, Neuropsychopharmacology.

[46]  Michael Q. Zhang,et al.  Integrative analysis of 111 reference human epigenomes , 2015, Nature.

[47]  Ruth C. Brown,et al.  Genetic Determinants of Depression: Recent Findings and Future Directions , 2015, Harvard review of psychiatry.

[48]  Bruce Guthrie,et al.  Depression and multimorbidity: a cross-sectional study of 1,751,841 patients in primary care. , 2014, The Journal of clinical psychiatry.

[49]  Han Xu,et al.  Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases. , 2014, American journal of human genetics.

[50]  Carson C Chow,et al.  Second-generation PLINK: rising to the challenge of larger and richer datasets , 2014, GigaScience.

[51]  Angelita Pui-Yee Wong,et al.  Investigating the possible causal association of smoking with depression and anxiety using Mendelian randomisation meta-analysis: the CARTA consortium , 2014, BMJ Open.

[52]  Roland Eils,et al.  circlize implements and enhances circular visualization in R , 2014, Bioinform..

[53]  Ina Schuppe-Koistinen,et al.  Skeletal Muscle PGC-1α1 Modulates Kynurenine Metabolism and Mediates Resilience to Stress-Induced Depression , 2014, Cell.

[54]  A. Quinlan BEDTools: The Swiss‐Army Tool for Genome Feature Analysis , 2014, Current protocols in bioinformatics.

[55]  C. Spencer,et al.  Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.

[56]  Walter Heindel,et al.  Establishing the bidirectional relationship between depression and subclinical arteriosclerosis – rationale, design, and characteristics of the BiDirect Study , 2014, BMC Psychiatry.

[57]  Jean-Paul Fox,et al.  Harmonization of Neuroticism and Extraversion phenotypes across inventories and cohorts in the Genetics of Personality Consortium: an application of Item Response Theory , 2014, Behavior genetics.

[58]  John Wei,et al.  Disruption of the ASTN2/TRIM32 locus at 9q33.1 is a risk factor in males for autism spectrum disorders, ADHD and other neurodevelopmental phenotypes. , 2014, Human molecular genetics.

[59]  T. Meehan,et al.  An atlas of active enhancers across human cell types and tissues , 2014, Nature.

[60]  M. Daly,et al.  LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.

[61]  C. Sudlow,et al.  UK Biobank Data: Come and Get It , 2014, Science Translational Medicine.

[62]  Jonathan J. Evans,et al.  Prevalence and Characteristics of Probable Major Depression and Bipolar Disorder within UK Biobank: Cross-Sectional Study of 172,751 Participants , 2013, PloS one.

[63]  R. Young,et al.  Super-Enhancers in the Control of Cell Identity and Disease , 2013, Cell.

[64]  Joshua F. McMichael,et al.  DGIdb - Mining the druggable genome , 2013, Nature Methods.

[65]  Archie Campbell,et al.  Cohort Profile: Generation Scotland: Scottish Family Health Study (GS:SFHS). The study, its participants and their potential for genetic research on health and illness. , 2013, International journal of epidemiology.

[66]  R. Araya,et al.  Early menarche and depressive symptoms from adolescence to young adulthood in a UK cohort. , 2013, Journal of the American Academy of Child and Adolescent Psychiatry.

[67]  M. Daly,et al.  Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis , 2013, The Lancet.

[68]  N. Wray,et al.  A mega-analysis of genome-wide association studies for major depressive disorder , 2013, Molecular Psychiatry.

[69]  Peter Kraft,et al.  A Genome-Wide Association Study of Depressive Symptoms , 2013, Biological Psychiatry.

[70]  S. Cichon,et al.  Meta-analysis and brain imaging data support the involvement of VRK2 (rs2312147) in schizophrenia susceptibility , 2012, Schizophrenia Research.

[71]  Jacy L. Wagnon,et al.  CELF4 Regulates Translation and Local Abundance of a Vast Set of mRNAs, Including Genes Associated with Regulation of Synaptic Function , 2012, PLoS genetics.

[72]  I. Gotlib,et al.  Depressive rumination and the C957T polymorphism of the DRD2 gene , 2012, Cognitive, Affective, & Behavioral Neuroscience.

[73]  Raymond K. Auerbach,et al.  An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.

[74]  Neelroop Parikshak,et al.  RBFOX1 regulates both splicing and transcriptional networks in human neuronal development. , 2012, Human molecular genetics.

[75]  L. Vatten,et al.  The causal role of smoking in anxiety and depression: a Mendelian randomization analysis of the HUNT study , 2012, Psychological Medicine.

[76]  N. Tommerup,et al.  Haploinsufficiency of CELF4 at 18q12.2 is associated with developmental and behavioral disorders, seizures, eye manifestations, and obesity , 2012, European Journal of Human Genetics.

[77]  P. Visscher,et al.  Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits , 2012, Nature Genetics.

[78]  H. Stefánsson,et al.  Common variants at VRK2 and TCF4 conferring risk of schizophrenia. , 2011, Human molecular genetics.

[79]  Albert J. Vilella,et al.  A high-resolution map of human evolutionary constraint using 29 mammals , 2011, Nature.

[80]  Ricardo Araya,et al.  Smoking Is Associated with, but Does Not Cause, Depressed Mood in Pregnancy – A Mendelian Randomization Study , 2011, PloS one.

[81]  A. Urani,et al.  The antidepressant-like effect of the 3β-hydroxysteroid dehydrogenase inhibitor trilostane involves a regulation of β-type estrogen receptors , 2011, Psychopharmacology.

[82]  Josyf Mychaleckyj,et al.  Robust relationship inference in genome-wide association studies , 2010, Bioinform..

[83]  W. Pelham,et al.  Very early predictors of adolescent depression and suicide attempts in children with attention-deficit/hyperactivity disorder. , 2010, Archives of general psychiatry.

[84]  M. Daly,et al.  Case-control genome-wide association study of attention-deficit/hyperactivity disorder. , 2010, Journal of the American Academy of Child and Adolescent Psychiatry.

[85]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[86]  M. Hatten,et al.  Astn2, A Novel Member of the Astrotactin Gene Family, Regulates the Trafficking of ASTN1 during Glial-Guided Neuronal Migration , 2010, The Journal of Neuroscience.

[87]  R. Araya,et al.  Cigarette smoking and depression: a question of causation , 2010, British Journal of Psychiatry.

[88]  D. Fergusson,et al.  Cigarette smoking and depression: tests of causal linkages using a longitudinal birth cohort , 2010, British Journal of Psychiatry.

[89]  Ming D. Li,et al.  Genome-wide meta-analyses identify multiple loci associated with smoking behavior , 2010, Nature Genetics.

[90]  E. Kang,et al.  A longitudinal study on the causal association between smoking and depression. , 2010, Journal of preventive medicine and public health = Yebang Uihakhoe chi.

[91]  A. Garnham,et al.  Exercise‐induced histone modifications in human skeletal muscle , 2009, The Journal of physiology.

[92]  E. Demerath,et al.  Meta-analysis of genome-wide association data identifies two loci influencing age at menarche , 2009, Nature Genetics.

[93]  D. Gudbjartsson,et al.  Genome-wide association study identifies sequence variants on 6q21 associated with age at menarche , 2009, Nature Genetics.

[94]  S. Potkin,et al.  Gene discovery through imaging genetics: identification of two novel genes associated with schizophrenia , 2009, Molecular Psychiatry.

[95]  Susanne Walitza,et al.  Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies , 2008, Journal of Neural Transmission.

[96]  Y. Xing,et al.  A Transcriptome Database for Astrocytes, Neurons, and Oligodendrocytes: A New Resource for Understanding Brain Development and Function , 2008, The Journal of Neuroscience.

[97]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[98]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[99]  A. Bonci,et al.  The Dopamine D2 Receptor: New Surprises from an Old Friend , 2005, Neuron.

[100]  Olga V. Demler,et al.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.

[101]  Michel Bourin,et al.  Dopamine, depression and antidepressants , 2004, Fundamental & clinical pharmacology.

[102]  M. Rimpelä,et al.  Pubertal timing, sexual behaviour and self-reported depression in middle adolescence. , 2003, Journal of adolescence.

[103]  A. Fernández-Guasti,et al.  Antidepressant-Like Effect of Different Estrogenic Compounds in the Forced Swimming Test , 2003, Neuropsychopharmacology.

[104]  T. Cooper,et al.  The CELF Family of RNA Binding Proteins Is Implicated in Cell-Specific and Developmentally Regulated Alternative Splicing , 2001, Molecular and Cellular Biology.

[105]  L. Stead,et al.  Anxiolytics for smoking cessation. , 2000, The Cochrane database of systematic reviews.

[106]  P. Sullivan,et al.  Genetic epidemiology of major depression: review and meta-analysis. , 2000, The American journal of psychiatry.

[107]  V. Ambros,et al.  The Cold Shock Domain Protein LIN-28 Controls Developmental Timing in C. elegans and Is Regulated by the lin-4 RNA , 1997, Cell.

[108]  Melissa C. Greven,et al.  An integrated encyclopedia of DNA elements in the human genome , 2014 .

[109]  D. Strachan,et al.  Genetic variation in LIN28B is associated with the timing of puberty. , 2009, Nature genetics.

[110]  M. Munafo,et al.  Effects of progression to cigarette smoking on depressed mood in adolescents: evidence from the National Longitudinal Study of Adolescent Health. , 2008, Addiction.

[111]  M. First,et al.  Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research version (SCID-I RV) , 2002 .

[112]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[113]  Edinburgh Research Explorer Genome-wide association study of depression phenotypes in UK Biobank identifies variants in excitatory synaptic pathways , 2022 .